Technical Analysis for NARI - Inari Medical, Inc.

Grade Last Price % Change Price Change
grade B 64.6 1.49% 0.95
NARI closed up 1.49 percent on Friday, September 25, 2020, on 46 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical NARI trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 1.49%
NR7 Range Contraction 1.49%
Wide Bands Range Expansion 1.49%
Oversold Stochastic Weakness 1.49%
50 DMA Resistance Bearish -1.24%
Inside Day Range Contraction -1.24%
Oversold Stochastic Weakness -1.24%
Older End-of-Day Gignals for NARI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 2 days ago
Outside Day 2 days ago
Up 2% 2 days ago
Down 1% 2 days ago
Up 1% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
Medicine Disease Catheter FDA Hematology Blood Clots Deep Vein Thrombosis Thrombosis Angiology Embolectomy Pulmonary Embolism Venous Thromboembolism

Is NARI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 84.9052
52 Week Low 39.55
Average Volume 298,958
200-Day Moving Average 0.00
50-Day Moving Average 67.16
20-Day Moving Average 71.84
10-Day Moving Average 68.74
Average True Range 4.49
ADX 22.92
+DI 15.79
-DI 22.10
Chandelier Exit (Long, 3 ATRs ) 71.42
Chandelier Exit (Short, 3 ATRs ) 75.98
Upper Bollinger Band 83.28
Lower Bollinger Band 60.39
Percent B (%b) 0.18
BandWidth 31.86
MACD Line -1.07
MACD Signal Line 0.51
MACD Histogram -1.5838
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 69.16
Resistance 3 (R3) 68.97 67.25 68.40
Resistance 2 (R2) 67.25 66.09 67.35 68.15
Resistance 1 (R1) 65.93 65.37 66.59 66.12 67.89
Pivot Point 64.21 64.21 64.55 64.31 64.21
Support 1 (S1) 62.89 63.05 63.55 63.08 61.31
Support 2 (S2) 61.17 62.33 61.27 61.05
Support 3 (S3) 59.85 61.17 60.80
Support 4 (S4) 60.04